Terumo Corp (4543 JP)

3rd Quarter Financial Results for FYE 3/2022

Speakers

• Naoki Muto (Executive Officer, Chief Accounting and Financial Officer, Terumo Corporation)
• Kenichi Hata (General Manager of Investor Relations Department, Terumo Corporation)

Analysts

• Shinnosuke Tokumoto (Analyst, SMBC Nikko Securities Inc.)
• Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
• Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
• Steven Liu (Analyst, CLSA Securities Japan Co., Ltd.)
• Stephen Barker (Analyst, Jefferies Japan Limited)
• Naoya Miura (Analyst, Jefferies Japan Limited)
• Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
• Tomoko Yoshihara (Analyst, Daiwa Securities Co. Ltd.)
• Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
• Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
• Ritsuo Watanabe (Analyst, BofA Securities Japan Co., Ltd.)
• Takahiro Mori (Analyst, Mizuho Securities Co., Ltd.)
• Mie Yamazaki (Analyst, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
• Ryotaro Hayashi (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
• Yukihiro Koike (Analyst, UBS Securities Japan Co., Ltd.)

New Medium- to long-term Growth Strategy Briefing Q&A

Speakers

• Shinjiro Sato (President and CEO, Terumo Corporation)
• Toshihiko Osada (Managing Executive Officer, President, Cardiac and Vascular Company, Terumo Corporation)
• Hikaru Samejima (Managing Executive Officer, President, General Hospital Company, Terumo Corporation)
• Fumihisa Hirose (Senior Executive Officer, General Manager, Strategic Planning Dept., Terumo Corporation)
• Antoinette Gawin (Executive Officer, President, Blood and Cell Technologies Company, Terumo Corporation)
• Naoki Muto (Executive Officer, Chief Accounting and Financial Officer, Terumo Corporation)
• Kenichi Hata (General Manager of Investor Relations Department, Terumo Corporation)

Analysts

• Shinnosuke Tokumoto (Analyst, SMBC Nikko Securities Inc.)
• Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
• Stephen Barker (Analyst, Jefferies Japan Limited)
• Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
• Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
• Ritsuo Watanabe (Analyst, BofA Securities Japan Co., Ltd.)
• Takahiro Mori (Analyst, Mizuho Securities Co., Ltd.)
• Ryotaro Hayashi (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
• Yukihiro Koike (Analyst, UBS Securities Japan Co., Ltd.)

Duration

• Presentation: 63 minutes
• Q&A: 63 minutes

New Medium- to long-term Growth Strategy Briefing Part 2

Speakers

• Fumihisa Hirose (Senior Executive Officer, General Manager, Strategic Planning Department, Terumo Corporation)
• Antoinette Gawin (Executive Officer, President, Blood and Cell Technologies Company, Terumo Corporation)
• Kenichi Hata (General Manager of Investor Relations Department, Terumo Corporation)

Duration

• Presentation: 0 minutes
• Q&A: 0 minutes

New Medium- to long-term Growth Strategy Briefing Part 1

Speakers

• Shinjiro Sato (President and CEO, Terumo Corporation)
• Toshihiko Osada (Managing Executive Officer, President, Cardiac and Vascular Company, Terumo Corporation)
• Hikaru Samejima (Managing Executive Officer, President, General Hospital Company, Terumo Corporation)
• Kenichi Hata (General Manager of Investor Relations Department, Terumo Corporation)

Duration

• Presentation: 0 minutes
• Q&A: 0 minutes

First Half Financial Results for the Fiscal Year Ending Mar. 2022

Speakers

• Shinjiro Sato (President and CEO, Terumo Corporation)
• Naoki Muto (Executive Officer, Chief Accounting and Financial Officer, Terumo Corporation)
• Kenichi Hata (General Manager of Investor Relations Department, Terumo Corporation)

Analysts

• Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
• Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
• Ritsuo Watanabe (Analyst, BofA Securities Japan Co., Ltd.)
• Yukihiro Koike (Analyst, UBS Securities Japan Co., Ltd.)